Answers are grounded in this paper and cite their sources.
Treatment of patients with single-ventricle defects according to the Fontan principle has arguably been one of the greatest achievements in congenital heart surgery. However, despite successful palliation, these patients can develop Fontan failure with end-organ dysfunction. Heart transplantation should be recommended after all possible remediable causes of Fontan failure have been addressed. There is no clear agreement about when a patient with Fontan failure should be referred for transplantation, but all would agree that it is best to transplant before severe end-organ injury. Mechanical circulatory support with VAD can reverse end-organ dysfunction and improve chances for a successful transplant. Transplantation following Fontan palliation is more technically challenging, but survival in the short and long term is nearly as good as transplant for cardiomyopathy. Perhaps in patients in whom the Fontan circulation results in complications and dysfunction, we should not consider it a failure, rather a not-unexpected outcome and that transplantation is the final stage of the single-ventricle treatment pathway.
No takes yet. Share an insight, caveat, or question.
Rajab et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: